Pulse Biosciences, Inc.

medical devices

About

Pulse Biosciences, Inc. is a clinical-stage bioelectric medicine company based in Hayward, California. The company focuses on developing innovative medical technologies that utilize nanosecond pulsed electric fields for therapeutic purposes. Its core technology, Nanosecond Pulsed Field Ablation (nsPFA), delivers ultra-short electrical pulses to selectively ablate targeted cells without the use of drugs or heat, providing a local and drug-free treatment option. Pulse Biosciences markets its technology under the brand names CellFX and nsPFA, with applications in various medical fields such as cardiology, dermatology, oncology, minimally invasive therapies, aesthetics, and veterinary medicine. The CellFX system is designed for precise tissue ablation, enhancing treatment outcomes while minimizing collateral damage. The company is dedicated to health innovation and improving patient quality of life, employing around 56 people and reporting revenues of approximately $14 million. Pulse Biosciences is publicly traded under the symbol PLSE and is recognized for its strong company culture and employee satisfaction.

Technologies

Salesforce Sendgrid Outlook Microsoft Office 365 Drupal Citrix NetScaler Remote

Keywords

immunooncology innovation atrial fibrillation cardiac surgery cardiology biology nanosecond pulsing medical/dental instruments health care medical equipment manufacturing cell sparing ablation regulatory approval process b2b dermatology electroporation therapy patient-centered solutions nspfa minimally invasive therapy safety and efficacy services clinical efficacy non-thermal technology medical devices electrical energy pulses clinical trials surgical ablation medical device innovation patient outcome improvement clinical research minimally invasive cardiac therapy

Location

3957 Point Eden Way, Hayward, California, United States, 94545

Related Companies

Companies in the same industry